1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Infectious Disease Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Infectious Disease Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Infectious Disease Diagnostics Market Regional Analysis
6.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Infectious Disease Diagnostics Market Forecast Analysis
7. Middle East & Africa Infectious Disease Diagnostics Market Analysis – by Product
7.1 Kits & Reagents
- 7.1.1 Overview
- 7.1.2 Kits & Reagents: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Software & Services
- 7.3.1 Overview
- 7.3.2 Software & Services: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa Infectious Disease Diagnostics Market Analysis – by Technology
8.1 Biosensor-Based
- 8.1.1 Overview
- 8.1.2 Biosensor-Based: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Immunodiagnostics
- 8.2.1 Overview
- 8.2.2 Immunodiagnostics: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Molecular-Based Diagnostic Techniques
- 8.3.1 Overview
- 8.3.2 Molecular-Based Diagnostic Techniques: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Clinical Biology
- 8.4.1 Overview
- 8.4.2 Clinical Biology: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa Infectious Disease Diagnostics Market Analysis – by Application Type
9.1 Laboratory Testing and Point-of-Care Testing
- 9.1.1 Overview
- 9.1.2 Laboratory Testing and Point-of-Care Testing: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa Infectious Disease Diagnostics Market Analysis – by Testing Type
10.1 Human Testing and Veterinary Testing
- 10.1.1 Overview
- 10.1.2 Human Testing and Veterinary Testing: Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Middle East & Africa Infectious Disease Diagnostics Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Middle East & Africa Infectious Disease Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.1.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.1.3 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.1.4 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Testing Type
- 11.2.1.2 Saudi Arabia:
Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Testing Type
- 11.2.1.3 UAE:
Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.3.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.3.3 UAE: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.3.4 UAE: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Testing Type
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Infectious Disease Diagnostics Market Breakdown, by Testing Type
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Bruker Corp
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Cardinal Health Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Trinity Biotech Plc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Danaher Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bio-Rad Laboratories Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 ACON Laboratories Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 DiaSorin SpA
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations